E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/11/2016 in the Prospect News Investment Grade Daily.

New Issue: Amgen details pricing of $3.75 billion senior notes in four tranches

By Lisa Kerner

Charlotte, N.C., Aug. 11 – Amgen Inc. priced $3.75 billion of five-, seven- and 10-year senior notes (Baa1/A) and an add-on to its 4.4% senior notes due 2045 on Thursday, according to an FWP filed with the Securities and Exchange Commission.

Some details of the issuance were reported on Wednesday.

The company priced $750 million of 1.85% five-year notes at 99.891 to yield 1.873%. The notes sold at 80 basis points over Treasuries, on the tight side of guidance of 85 bps, plus or minus 5 bps, over Treasuries.

Amgen sold $750 million of 2.25% seven-year notes at 99.749 to yield 2.289%. The notes priced at 95 bps over Treasuries and were guided at 100 bps over Treasuries, plus or minus 5 bps.

The company placed $1.25 billion of 2.6% 10-year notes at 110 bps over Treasuries, on the tight side of guidance of 115 bps, plus or minus 5 bps, over Treasuries. The notes sold at 99.939 to yield 2.607%.

Amgen priced a $1 billion add-on to its 4.4% senior notes due May 1, 2045 at 107.892 to yield 3.934%, or Treasuries plus 170 bps. The notes were guided at 175 bps, plus or minus 5 bps, over Treasuries.

Amgen originally sold $1.25 billion of the bonds on April 28, 2015 at 175 bps over Treasuries. The total outstanding is $2.25 billion.

The bookrunners were Citigroup Global Markets Inc., Goldman Sachs & Co., HSBC Securities (USA) Inc. and Morgan Stanley & Co. LLC.

Proceeds will be used to repay debt, including borrowings under the company’s term loan credit agreement, to repurchase common stock and for general corporate purposes, according to a 424B3 filed with the SEC.

Amgen is a Thousand Oaks, Calif., manufacturer and marketer of human therapeutics based upon advances in cellular and molecular biology.

Issuer:Amgen Inc.
Amount:$3.75 billion
Description:Senior notes
Bookrunners:Citigroup Global Markets Inc., Goldman Sachs & Co., HSBC Securities (USA) Inc., Morgan Stanley & Co. LLC
Senior co-managers:Barclays, J.P. Morgan Securities LLC, Mizuho Securities USA Inc., RBC Capital Markets, LLC, UBS Securities LLC
Co-managers:Academy Securities, Inc., BNP Paribas Securities Corp., Credit Suisse Securities (USA) LLC, Deutsche Bank Securities Inc., BofA Merrill Lynch, MUFG, SMBC Nikko Securities America, Inc., Wells Fargo Securities LLC
Trade date:Aug. 10
Settlement date:Aug. 19
Ratings:Moody’s: Baa1
S&P: A
Fitch: BBB (for 2045 notes)
Distribution:SEC registered
Five-year notes
Amount:$750 million
Maturity:Aug. 19, 2021
Coupon:1.85%
Price:99.891
Yield:1.873%
Spread:Treasuries plus 80 bps
Price guidance:Treasuries plus 85 bps area, plus or minus 5 bps
Seven-year notes
Amount:$750 million
Maturity:Aug. 19, 2023
Coupon:2.25%
Price:99.749
Yield:2.289%
Spread:Treasuries plus 95 bps
Price guidance:Treasuries plus 100 bps area, plus or minus 5 bps
10-year notes
Amount:$1.25 billion
Maturity:Aug. 19, 2026
Coupon:2.6%
Price:99.939
Yield:2.607%
Spread:Treasuries plus 110 bps
Price guidance:Treasuries plus 115 bps area, plus or minus 5 bps
Add-on notes
Amount:$1 billion reopening
Maturity:May 1, 2045
Coupon:4.4%
Price:107.892 plus accrued interest from May 1, 2016
Yield:3.934%
Spread:Treasuries plus 170 bps
Price guidance:Treasuries plus 175 bps area, plus or minus 5 bps
Total outstanding:$2.25 billion, including $1.25 billion priced on April 28, 2015 at 175 bps over Treasuries

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.